Biological availability of ophthalmic preparations 2. Ophthalmic therapeutic systems;Biologická dostupnost očních léků 2. Oční terapeutické systémy

Ceska a Slovenska Farmacie

Volumn 53, Issue 5, 2004, Pages 211-218

  Masteiková, Ruta ^a   Chalupova Z ^a   Savickas, A ^b  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b Kat Farmaceut Chemie Farmakognozie   (Lithuania)

Author keywords

Biological availability; Eye implants; Eye inserts; Ophthalmic therapeutic systems; Therapeutic eye lenses

Indexed keywords

AGENTS ACTING ON THE EYE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CHITOSAN; CIPROFLOXACIN; COLLAGEN; CORTICOSTEROID; CYCLOSPORIN; ETHYL CELLULOSE; EUDRAGIT; EUDRAGIT RS; FIBRIN; FLUOCINOLONE; FLUOROURACIL; GANCICLOVIR; HYALURONIC ACID; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; METHYLCELLULOSE; PILOCARPINE; POLYACRYLIC ACID; POLYMACON; POLYMER; POLYVINYL ACETATE; POVIDONE; TRIAMCINOLONE; UNINDEXED DRUG; XANTHAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOAVAILABILITY; COLLOID; CONTROLLED DRUG RELEASE; CYTOMEGALOVIRUS INFECTION; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; EYE DISEASE; EYE IMPLANT; EYE INSERT; HUMAN; HYDROGEL; OPHTHALMIC THERAPEUTIC SYSTEM; RETINITIS; REVIEW; SOLUBILITY; SOLUBLE OCULAR DRUG INSERT; THERAPEUTIC EYE LENS; EYE; HYDROPHILIC CONTACT LENS; METABOLISM;

BIOLOGICAL AVAILABILITY; CONTACT LENSES, HYDROPHILIC; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; EYE; HUMANS;

EID: 4444369906     PISSN: 12107816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Desai, S. D., Blanchard, J.: In: Encyclopedia of Pharmaceutical Technology (Swarbrick, J., Boylan, J. C., eds.), New York, Basel and Hong Kong, Marcel Dekker, 1995, s. 43.
2. Krishnamoorthy, R., Mitra, A. K.: In: Ophthalmic Drug Delivery Systems (Mitra, A. K., ed.), New York, Basel and Hong Kong, Marcel Dekker, 1993, s. 199.
3. Saettone, M. F.: In: Biopharmaceutics of Ocular Drug Delivery (Edman, P., ed.), Boca Raton, CRC Press, 1993, s. 61.
4. th ed., New York and Basel, Marcel Dekker, 2002, s. 415.
5. Bourlais, C. L. et al.: Progr. Retinal Eye Res., 1998; 17, 33-58.
6. Bawa, R.: In: Ophthalmic Drug Delivery Systems (Mitra, A. K, ed.), New York, Basel and Hong Kong, Marcel Dekker, 1993, s. 223.
7. Kulkarni, S. P. et al.: Drug Devel. Ind. Pharm., 1997; 23, 465-471.
8. th ed., Easton, Mack Publishing Comp., 1995, s. 1563.
9. rd ed., London, Macmillan Press, 1998, s. 373.
10. Charoo, N. A. et al.: Drug Devel. Ind. Pharm., 2003; 29, 215-221.
11. Lim, L., Tan, D. T., Chan, W. K.: CLAO J., 2001; 27, 179-185.
12. Srur, M., Dattas, D.: CLAO J., 1997; 23, 40-42.
13. Hull, D. S., Edelhauser H. F., Hyndiuk, R. A.: Arch. Ophthalmol., 1974; 92, 413-416.
14. Hillman, J. S., Marsters, J. B., Broad, A.: Transactions of the Ophthalmological Societies of the United Kingdom, 1975; 95, 79-84.
15. Sintzel, M. B. et al.: Eur. J. Pharm. Biopharm., 1996; 42, 358-374.
16. Kaur, I. P., Kanwar, M.: Drug Devel. Ind. Pharm., 2002; 28, 473-493.
17. Karlgard, C. C. S. et al.: Int. J. Pharm., 2003; 257, 141-151.
18. Lloyd, A. W. et al: Biomaterials, 2001; 22, 769-785.
19. Hehl, E. M. et al.: Eur. J. Clin. Pharmacol., 1999; 55, 317-323.
20. Kalayci, D. et al.: CLAO J., 1999; 25, 182-184.
21. Keipert, S.: In: Moderné lieky vo farmaceutickej technológii (Žabka, M., Müller, R. H., Hildebrand, G. E., eds.), 1. slov. vyd., Bratislava, Slovak Academic Press, 1999, s. 77.
22. Lesher, G. A., Gunderson, G. G.: Optometry Vis. Sci., 1993; 70, 1012-1018.
23. Smiddy, W. E. et al.: Ophthalmology, 1990; 97, 291-295.
24. Donnenfeld, E. D. et al.: Ophthalmology, 1995; 102, 979 až 984.
25. Alvarez-Lorenzo, C. et al.: J. Pharm. Sci., 2002; 91, 2182-2192.
26. Hiratani, H., Alvarez-Lorenzo, C.: J. Control. Release, 2002; 83, 223-230.
27. Sano, K., Tokoro, T., Imai, Y.: Int. Contact Lens Clinic, 1996; 23, 242.
28. Sutinen, R. et al.: Int. J. Pharm., 1990; 62, 113-118.
29. Chetoni, P. et al.: Eur. J. Pharm. Biopharm., 1998; 46, 125-132.
30. Urtti, A. et al.: Int. J. Pharm., 1990; 61, 241-249.
31. Urtti, A. et al.: Pharm. Res., 1994; 11, 1278-1282.
32. Sasaki, H. et al.: J. Control. Release, 1993; 27, 127-137.
33. Kawakami, S. et al.: J. Control. Release, 2001; 76, 255 až 263.
34. Hsiue, G.-H., Guu, J.-A., Cheng, C.-C.: Biomaterials, 2001; 22, 1763-1769.
35. Hornof, M. et al.: J. Control. Release, 2003; 89, 419-428.
36. Dostálová, M., Rabišková, M.: Čes. slov. Farm., 2000; 49, 55-61.
37. Jaffe, G. J. et al.: Ophthalmology, 2000; 107, 2024-2033.
38. Gilger B. C. et al.: Am. J. Veter. Res., 2001; 62, 1892-1896.
39. Kurz, D., Ciulla, T. A.: Ophthalmol. Clin. North Am., 2002; 15, 405-410.
40. Ogura, Y.: Adv. Drug Deliv. Rev., 2001; 52, 1-3.
41. First eye implant approved: AIDS Alert, 1996; 11, 59.
42. Anand, R.: Curr. Opinion Ophthalmol., 1997; 8, 8-14.
43. Martin, D. F. et al.: Am. J. Ophthalmol., 1999; 127, 329-339.
44. Roth, D. B. et al.: Am. J. Ophthalmol., 1999; 127, 276-282.
45. Kuo, I. C. et al.: Am. J. Ophthalmol., 2003; 135, 20-25.
46. Jabs, D. A. et al.: Am. J. Ophthalmol., 2003; 135, 26-34.
47. Cadman, J.: GMHC Treatment Issues, 1997; 11, 3-6.
48. MacCumber, M. W. et al.: Arch. Ophthalmol., 1999; 117, 1250-1254.
49. Dhillon, B., Kamal, A., Leen, C.: Int. J. STD&AIDS, 1998; 9, 227-230.
50. Jaffe, G. J. et al.: Invest. Ophthalmol. Vis. Sci., 2000; 41, 3569-3575.
51. Robinson, M. R. et al.: Exp. Eye Res., 2002; 74, 309-317.
52. Klimas, R. et al.: Medicina, 2003; 39, 96-103.
53. Lux, A. et al.: Brit. J. Ophthalmol., 2003; 87, 436-440.
54. Willoughby, C. E. et al.: Surv. Ophthalmol., 2002; 47, 174-182.
55. Friess, W.: Eur. J. Pharm. Biopharm., 1998; 45, 113-136.
56. Kuwano, M., Horibe, Y., Kawashima, Y.: J. Ocul. Pharmacol. Ther., 1997; 13, 31-40.
57. Renard, G.: J. Cataract Refract. Surg., 1993; 19, 48-51.
58. Milani, J. K. et al.: Am. J. Ophthalmol., 1993; 116, 622 až 627.
59. Callegan, M. C. et al.: Curr. Eye Res., 1994; 13, 875-878.
60. Callegan, M. C. et al.: Int. J. Pharm., 1995; 123, 173-179.
61. Taravella, M. J. et al.: J. Cataract Refract. Surg., 1999; 25, 562-565.
62. Schwartz, S. D. et al.: Am. J. Ophthalmol., 1990; 109, 701-704.
63. Pleyer, U. et al.: Am. J. Ophthalmol., 1992; 113, 303-308.
64. Mendicute, J. et al.: CLAO J., 1995; 21, 252-255.
65. Gebhardt, B. M., Kaufman, H. E.: J. Ocul. Pharmacol. Ther., 1995; 11, 319-327.
66. Mahlberg, K., Uusitalo, R. J., Oksala, O.: Ocul. Immunol. Inflam., 1997; 5, 101-110.
67. st World Meeting APGI/APV, Budapest, 9/11 May 1995, s. 807.
68. Nadkarni, S. R., Yalkowsky, S. H.: Pharm. Res., 1993; 10, 109-112.
69. Hämäläinen, K. M. et al.: J. Control. Release, 1998; 56, 273-283.
70. Lee, Y.-C. et al.: Int. J. Pharm., 1999; 182, 121-126.
71. Lee, Y.-C., Simamora, P., Yalkowsky, S. H.: J. Pharm. Sci., 1997; 86, 1361-1364.
72. Lee, Y.-C., Yalkowsky, S. H.: Int. J. Pharm., 1999; 181, 71-77.
73. Lee, Y.-C., Yalkowsky, S. H.: Int. J. Pharm., 1999; 185, 199-204.
74. Lee, Y.-C., Yalkowsky, S. H.: Int. J. Pharm., 1999; 190, 35-40.
75. Saettone, M. F. et al.: Int. J. Pharm., 1992; 86, 159-166.
76. Kyyrönen, K. et al.: Int. J. Pharm., 1992; 80, 161-169.
77. Sanzgiri, Y. D. et al.: J. Control. Release, 1993; 26, 195 až 201.
78. Ceulemans, J. et al.: J. Control. Release, 2001; 77, 333 až 344.
79. Ramadan, E. M.: Pharm. Ind., 1998; 60, 808-811.
80. Zatloukal, Z.: Českosl. Farm., 1990; 39, 433-435.
81. Zatloukal, Z.: Čes. slov. Farm., 1998; 47, 276-278.
82. Bharath, S., Hiremath, S. R.: Pharmazie, 1999; 54, 55-58.
83. Baeyens, V. et al.: J. Control. Release, 1998; 52, 215-220.
84. Gurtler, F. et al.: J. Control. Release, 1995; 33, 231-236.
85. Gurtler, F. et al.: Pharm. Res., 1995; 12, 1791-1795.
86. Gurtler, F. et al.: Eur. J. Pharm. Biopharm., 1996; 42, 393-398.
87. st World Meeting APGI/APV, Budapest, 9/11 May 1995, s. 805.
88. Di Colo, G. et al.: Int. J. Pharm., 2002; 248, 115-122.
89. Wilson, C. G.: PSTT, 1999; 2, 321-326.
90. Richardson, M. C., Bentley, P. H.: In: Ophthalmic Drug Delivery Systems (Mitra, A.K., ed.), New York, Basel and Hong Kong, Marcel Dekker, 1993, s. 355.
91. Diestelhorst, M., Krieglstein G. K.: Int. Ophthalmol., 1994; 18, 1-4.
92. Lele, B. S., Hoffman, A. S.: J. Biomater. Sci., 2000; 11, 1319-1331.
93. Di Colo, G., Zambito, Y.: Eur. J. Pharm. Biopharm., 2002; 54, 193-199.
94. Di Colo, G. et al.: Int. J. Pharm., 2001; 215, 101-111.
95. Saettone, M. F. et al.: Int. J. Pharm., 1995; 126, 79-82.
96. Majčuk, J. F.: Glaznyje lekarstvennyje plenky [Oční léčivé folie], Moskva, Medexport, 1985, s. 67.
97. Calonge, M.: Surv. Ophthalmol., 2001; 45(2), 227-239.
98. Baeyens, V. et al.: J. Control. Release, 2002; 85, 163-168.
99. Yasukawa, T. et al: Adv. Drug Deliv. Rev., 2001; 52, 25-36.
100. Kimura, H., Ogura, Y.: Ophthalmologica, 2001; 215, 143-155.
101. Hashizoe, M. et al: Curr. Eye Res., 1995; 14, 473-477.
102. Hashizoe, M. et al: Curr. Eye Res., 1997; 16, 633-639.
103. Miyamoto, H. et al.: Curr. Eye Res., 1997; 16, 930-935.
104. Tan, D. T. et al.: Ophthalmology, 2001; 108, 2172-2181.
105. Morales, J. et al.: Curr. Eye Res., 1998; 17, 844-850.
106. Avitabile, T. et al.: Biomaterials, 2001; 22, 195-200.
107. Einmahl, S. et al.: Int. J. Pharm., 1999; 185, 189-198.
108. Einmahl, S. et al.: Adv. Drug Deliv. Rev., 2001; 53, 45-73.
109. Zhou, T. et al.: In: Proceed. Int'l. Symp. Control. Rel. Bioact. Mater., 1997; 24, 625-626.
110. Zhou, T. et al.: J. Control. Release, 1998; 55, 281-295.
111. Zignani, M. et al.: J. Control. Release, 1997; 48, 115-129.
112. Gilbert, J. A. et al.: J. Control. Release, 2003; 89, 409-417.
113. Yeh, M. K. et al.: J. Microencaps., 2001; 18, 507-519.
114. Merodio, M. et al.: Biomaterials, 2002; 23, 1587-1594.
115. Conti, B. et al.: Eur. J. Pharm. Sci., 1997; 5, 287-293.
116. Herero-Vanrell. R., Ramirez, L.: Pharm. Res., 2000; 17, 1323-1328.
117. Herero-Vanrell. R., Refojo, M. F.: Adv. Drug Deliv. Rev., 2001; 52, 5-16.
118. Diaz-Llopis, M. et al.: Docum. Ophthalmol., 1992; 82, 297-305
119. Akula, S. K. et al.: Br. J. Ophthalmol., 1994; 78, 677-680.
120. Meisner, D., Mezei, M.: Adv. Drug Deliv. Rev., 1995; 16, 75-93.
121. Cheng, L. et al.: Invest. Ophthalmol. Vis. Sci., 2000; 41, 1523-1532.
122. Bochot, A. et al.: Invest. Ophthalmol. Vis. Sci., 2002; 43, 253-259.